NCT06621485
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Beijing Tsinghua Changgung Hospital Beijing, China
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,054 public trials
1,183 recruiting studies
Adenocarcinoma trial results
NCT05363072
- Conditions
- Adenocarcinoma, Cancer of Kidney, Cancer of the Kidney, +19 more
- Locations
-
- Pfizer Finland Helsinki, Finland
NCT01350648
- Conditions
- Acquired Immunodeficiency Syndrome, Adenocarcinoma, Blood-Borne Infections, +32 more
- Locations
-
- VA Medical Center, Washington D.C. Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT02264210
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +18 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT01210482
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Kyusyu University Hospital Fukuoka, Fukuoka PREF, Japan
NCT05221398
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Jian-Hong Zhong Nanning, Guangxi, China
NCT03108066
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +35 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04160065
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
NCT05485896
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Changyi Quan Tianjin, Tianjin Municipality, China
NCT04375150
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Pfizer INC New York, United States